Analysts trim targets as CWEN heads toward Q3 results

Clearway Energy enters its October 30 earnings release with the Street still broadly bullish but quietly lowering its sights, even as short sellers show little sign of pressing their bets.

The analyst picture is the most active angle this week. UBS and Morgan Stanley both cut price targets on October 21, with UBS moving from $45 to $38 and Morgan Stanley from $58 to $52, each keeping their positive ratings intact. That follows earlier trims from Seaport Global and Truist Securities in late September. The direction of travel is consistent: analysts remain buyers but are reining in their upside assumptions. The gap between the Street's revised targets and the current price of $30.24 is still wide, implying substantial implied upside across the coverage universe. The consensus price target mean of $27.50 listed in older data should be treated with caution given its 2021 date; the recent individual targets in the $38 to $52 range are a far better read on where current analyst thinking sits.

Short positioning is notable in absolute terms but is heading in the wrong direction for bears. At 9.1% of the free float, Clearway carries a meaningfully elevated short interest for a contracted renewable utility. But the trend has run against the short thesis for weeks. Short interest has fallen roughly 3.3% over the past month and is down a further half percent on the week, settling at around 7.7 million shares. The borrow market does not corroborate any building pressure either: cost to borrow is just 0.56%, technically a one-week high after a 39% weekly rise, but still firmly in the cheap bracket. Availability is wide at 426%, with roughly 75 million shares available relative to the 7.7 million currently borrowed, meaning there is no structural squeeze risk in the lending pool.

Options positioning gives no strong directional read. The put/call ratio of 0.32 is almost exactly in line with its 20-day average of 0.32, with a z-score near zero. The 52-week range on the PCR runs from 0.08 to 0.33, placing the current reading close to the top of that band, but the signal is more about a calm, call-heavy structure than any acute defensive hedging. Options traders are not signalling alarm ahead of the print.

The bull case rests on Clearway's 7% to 8% projected CAGR through 2030, the contracted asset base under its sponsor pipeline, and the significant gap between the stock's current price and where analysts have their targets. The bear case centres on cash available for distribution coming in below expectations, high customer concentration, and the stock's sensitivity to financing costs given its yield-oriented structure. The EV/EBITDA multiple of 10.8x has compressed slightly over the past 30 days, consistent with the stock's 1.9% decline over the same period. Factor scores offer a mixed backdrop: EPS surprise ranks in the 89th percentile, a strong track record for beating estimates, while the dividend score of 33 and EV/EBIT rank of 5 point to a stock that screens expensive and carries a thinner income cushion than typical utilities.

Looking at the two most recent earnings prints, Clearway posted a 3.5% gain on the day of its August 2026 release and extended that to 8.4% over the following five days. The May 2026 print saw a 2.7% one-day drop but recovered to a 7.6% gain over the subsequent week. Both episodes resolved higher within a week, a pattern that may interest investors watching the setup into October 30, though the analyst target cuts suggest expectations have been reset since the August release.

The key question heading into the Q3 print is whether Clearway's CAFD guidance holds at a level consistent with its 7% to 8% growth target, and whether the sponsor pipeline delivers enough visibility to justify the gap between the stock and the revised but still elevated analyst price targets.